Phase 2 Crohn's Disease and Colitis Trial, Recruiting NCT06918808 Sponsor: Direct Biologics, LLC Condition: Crohn's Disease and Colitis
Back to Crohns Disease And Colitis

Phase 2 Crohn's Disease and Colitis Trial, Recruiting

NCT06918808
Recruiting Phase 2

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 75 years old and have been diagnosed with Crohn's Disease for at least 6 months
  • You have one or two perianal fistulas (abnormal tunnels near the anus) with one or two openings that are actively draining
  • You have tried at least one medical treatment in the past year (such as antibiotics, immune-suppressing drugs, or biologic injections) that did not work well enough
  • You either tried surgery (including a seton drain placed at least 2 weeks before screening), are not a candidate for surgery, or do not wish to have surgery for your fistula
  • Your current Crohn's Disease medications have been at a stable dose for at least 2 months before starting the trial
  • If you take antibiotics for Crohn's Disease, your dose has been stable for at least 2 weeks before starting the trial
  • If you take oral steroids, your dose is no more than 20 mg per day of prednisone (or equivalent) and has been stable for at least 4 weeks before starting
  • You are able to have a pelvic MRI scan, and the scan results meet specific requirements reviewed by a specialist radiologist (confirm with trial site)
  • Your MRI scan shows the fistula meets specific size, location, and tissue characteristics as assessed by a central radiologist (confirm with trial site)

Who may not be able to join:

  • You did not provide written consent to participate
  • You are pregnant, breastfeeding, or are a woman who could become pregnant without a confirmed negative pregnancy test
  • You are unwilling to use an acceptable form of contraception during the study
  • You have an active abscess or infection near the anus at the time of screening or at the start of the trial
  • You have had a significant health condition within the past 6 months that the study doctor feels could put you at risk
  • You have a confirmed diagnosis of HIV, Hepatitis B, or Hepatitis C
  • You have a history of cancer, including melanoma, within the past year (minor non-melanoma skin cancers may be an exception)
  • You have a history of colorectal (bowel) cancer within the past 2 years
  • You have a bleeding or clotting disorder, or you currently take blood-thinning medication
  • You have a fistula connecting the rectum or anus to the vagina
  • You have had your rectum surgically removed, or you have an internal pouch (ileal anal pouch)
  • You have severe inflammation of the rectum, based on a specific scoring system (confirm with trial site)
  • You are unable to safely have an MRI scan (for example, due to certain metal implants, body weight limits, or severe claustrophobia)
  • Your blood test results at screening fall outside acceptable ranges, including abnormal white blood cell count, low hemoglobin (signs of anaemia), low platelets, abnormal liver or kidney values, abnormal clotting levels, or a blood sugar marker above a certain level (confirm with trial site for specific values)
  • You have taken part in another clinical trial or used an experimental treatment within 30 days before starting this trial
  • Your MRI scan shows the fistula does not meet the required location or structural criteria as assessed by a central radiologist (confirm with trial site)
  • Your MRI scan scores do not meet the minimum thresholds required for the study's imaging criteria (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: 1-800-791-1021

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 2
Sponsor
Direct Biologics, LLC
Registry
ClinicalTrials.gov
Start date
19 May 2025
Est. completion
30 July 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Combined Remission

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov